The film will go into limited release December 1.
NYS Entity Status
NYS Filing Date
JANUARY 14, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - AKHENATEN THE MUSICAL, LIMITED LIABILITY COMPANY
Around the Web
- Woody Allen’s ‘Wonder Wheel’ set to close NY Film Festival
By Deadline - Tuesday Jul 25, 2017
- Upstate NY’s Basilica Soundscape Is A Festival Of Intimate Juxtaposition: Pastoral Stillness, Frenetic Noise
By Caitlin White - Tuesday Sep 19, 2017
An LA native travels to Hudson, New York for one of the most intimate, noisiest and most picturesque festivals in the country
- N.Y. Company Accused of Running Bitcoin Ponzi Scheme
Thursday Sep 21, 2017
The CFTC has accused New York company Gelfman Blueprint of operating a bitcoin-related Ponzi scheme, in the regulator’s first fraud-related action involving the cryptocurrency.
- NY insurance company dragged into Wells Fargo scandal
By Kevin Dugan - Tuesday Aug 1, 2017
The New York insurance company that wrote policies for 800,000 questionable Wells Fargo auto loans has been dragged into the bank’s latest scandal. National General Insurance was named in a class-action lawsuit filed against the bank — for allegedly unduly profiting from $80 million in collateral protection insurance that the drivers didn’t need — and...
- NY Times sees jump in digital subscription revenue
By Reuters - Thursday Jul 27, 2017
The New York Times said on Thursday its digital subscription revenue overtook print advertising revenue for the first time — a key milestone in the 166-year old publisher’s efforts to transform itself into a digital media powerhouse. The company’s shares rose as much as 7 percent to their highest since the 2008 financial crisis as...
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]